These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 20674409

  • 1. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
    Bohluli B, Motamedi MH, Bagheri SC, Bayat M, Lassemi E, Navi F, Moharamnejad N.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ.
    Cephalalgia; 2012 Apr; 32(6):443-50. PubMed ID: 22492424
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U, Ilhan S, Alp R, Sur H.
    Clin Neuropharmacol; 2005 Apr; 28(4):161-2. PubMed ID: 16062093
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin in trigeminal neuralgia.
    Castillo-Álvarez F, Hernando de la Bárcena I, Marzo-Sola ME.
    Med Clin (Barc); 2017 Jan 06; 148(1):28-32. PubMed ID: 27743594
    [Abstract] [Full Text] [Related]

  • 5. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.
    Guardiani E, Sadoughi B, Blitzer A, Sirois D.
    Laryngoscope; 2014 Feb 06; 124(2):413-7. PubMed ID: 23818108
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain.
    Castiglione A, Bagnato S, Boccagni C, Romano MC, Galardi G.
    Arch Phys Med Rehabil; 2011 Jul 06; 92(7):1034-7. PubMed ID: 21704782
    [Abstract] [Full Text] [Related]

  • 7. [Trigeminal neuralgia: treatment options for refractory cases].
    Ruscheweyh R, Straube A.
    MMW Fortschr Med; 2019 May 06; 161(10):52-56. PubMed ID: 31129820
    [No Abstract] [Full Text] [Related]

  • 8. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
    Wei J, Zhu X, Yang G, Shen J, Xie P, Zuo X, Xia L, Han Q, Zhao Y.
    Brain Behav; 2019 Oct 06; 9(10):e01409. PubMed ID: 31541518
    [Abstract] [Full Text] [Related]

  • 9. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Xiao L, Mackey S, Hui H, Xong D, Zhang Q, Zhang D.
    Pain Med; 2010 Dec 06; 11(12):1827-33. PubMed ID: 21134121
    [Abstract] [Full Text] [Related]

  • 10. Botulinum Toxin Type A Injections as an Effective Treatment of Refractory Multiple Sclerosis-Related Trigeminal Pain - A Case Report.
    Calejo M, Salgado P, Moreira B, Correia C, Barros J.
    Headache; 2019 Sep 06; 59(8):1379-1381. PubMed ID: 31424566
    [No Abstract] [Full Text] [Related]

  • 11. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C, Díaz S, Piedimonte F, Micheli F.
    Arq Neuropsiquiatr; 2008 Sep 06; 66(3A):500-3. PubMed ID: 18813708
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
    Shehata HS, El-Tamawy MS, Shalaby NM, Ramzy G.
    J Headache Pain; 2013 Nov 19; 14(1):92. PubMed ID: 24251833
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M, Silva S, Cottrell C.
    Headache; 2008 Nov 19; 48(10):1476-81. PubMed ID: 19076646
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerations.
    Volcy M, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME.
    Cephalalgia; 2006 Mar 19; 26(3):336-40. PubMed ID: 16472343
    [No Abstract] [Full Text] [Related]

  • 15. Botulinum toxin for trigeminal neuralgia--do we have the evidence?
    Zakrzewska JM.
    Cephalalgia; 2012 Nov 19; 32(15):1154-5; author reply 1156-7. PubMed ID: 22990690
    [No Abstract] [Full Text] [Related]

  • 16. Trigeminal Neuralgia With Extraoral Trigger Zone Successfully Treated With Intraoral Injections of Botulinum Toxin: A Case Report.
    Dinan JE, Smith A, Hawkins JM.
    Clin Neuropharmacol; 2020 Nov 19; 43(5):162-163. PubMed ID: 32947428
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia.
    Liu J, Xu YY, Zhang QL, Luo WF.
    Pain Res Manag; 2018 Nov 19; 2018():7365148. PubMed ID: 29849847
    [Abstract] [Full Text] [Related]

  • 18. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K.
    Toxins (Basel); 2021 Aug 29; 13(9):. PubMed ID: 34564609
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin for trigeminal neuralgia.
    Nurmikko T, Cruccu G.
    Eur J Neurol; 2009 May 29; 16(5):e104. PubMed ID: 19405205
    [No Abstract] [Full Text] [Related]

  • 20. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
    Chankrachang S, Arayawichanont A, Poungvarin N, Nidhinandana S, Boonkongchuen P, Towanabut S, Sithinamsuwan P, Kongsaengdao S.
    Headache; 2011 Jan 29; 51(1):52-63. PubMed ID: 21083558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.